On February 28, 2022, legislators introduced the RIGHT DRUG RIGHT DOSE NOW Act, key sponsors Eric Swallwell (CA) and Tom Emmer (MN).
- See press release at Emmers web site here.
- See a PDF of the 17-page bill here.
- See deep dive/subscription coverage at Genomeweb here.
- See some pre-publicity, from December, at the PharmaGKB Blog website here.
- For a website for advocates "Fourth Cause" here.
From "Fourth Cause," which also posts a bill summary,
How does the Right Act address the barriers?
- Require an assessment and update of the National Action Plan for Adverse Drug Event Prevention;
- Create educational campaigns on preventing adverse drug events, in part through the use of evidence-based PGx information.
- Incentivize updates to electronic health record systems to ensure that healthcare providers are alerted to interactions between medications and genes when making prescribing decisions;
- Enhance reporting systems that would assist with the reporting of PGx-associated adverse drug events; and
- Authorize sustained funding for PGx implementation research and guideline development.